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Abstract 
In this study, 200 patients (100 male and 100 female) suffering from Urinary tract infection who presented to the 
Emergency Department of Babylon Maternity and Children Hospital  and Al-Hillah educational Hospital from 
October\2012 to February\2013 underwent a history and physical examination. In this study, Escherichia coli 
formed the major causative agent (10.8% in male and 13.2% in female) followed by staphylococcus aureus 
(5.4% in male and 4% in female), Pseudomonas aeruginosa (4% in male and 4.6% in female).  
All isolates were tested for the sensitivity to Amikacin, Chloromphenicol, Nitrofurantoin, Ofloxacin, Norfloxacin, 
while Pseudomonas aeruginosa shows sensitivity with Norfloxacin, Ofloxacin, Piperacillin, Tobramycin, Proteus 
species shows sensitivity with Amikacin, Amoxicillin , Cefodizime, Cefoxitin, Cephalexin, Gentamycin, , 
Norfloxacin, Piperacillin, Tobramycin and Klebsiella pneumoniae isolates shows sensitivity with Amikacin, 
Norfloxacin, Piperacillin, Tobramycin.  
Our investigation showed that from the 200 patients with UTI, 62 male and 84 had pyuria > 5 WBCs/hpf, 84 
male and 75 female had pyuria >10 WBCs/mL, 86 male and 64 female had CRP >24 mg/L, 67 male and 70 
female had ESR >35 mm/hour, and 69 male and 55 female had WBC >15 000/mL. 
 
Introduction 
Bacteria are the most frequent urinary pathogen isolated from 50-90 % of all uncomplicated urinary tract 
infections [1]. Urinary tract infections are very common infections in humans, with E. coli being the dominant 
pathogen. E. coli, the most common member of the family Enterobacteriaceae accounts for 75-90 % of all 
urinary tract infections in both patients and out patients [2]. The identification of nonpathogenic members also 
needs to detect factors that determine virulence of this organism [3]. 
The annual incidence of urinary tract infections (UTIs) in the elderly population ranges from 10% in the 
community to as high as 30% of hospitalized patients [4]. Mortality rates in elderly patients from bacteremia as a 
result of UTI can be as high as 33% [5]. A study by Plowman et al. (2001) [6] found that over a 12 month period 
UTIs had the highest incidence (35 %) of all nosocomial infections in a district general hospital, and the majority 
of patients were over 60 years of age.  
UTIs are also the most common infection in long-term care facilities, where they account for 20–60% of all 
antibiotic prescription use [7]. This large-scale prescription of antibiotics may well contribute to the levels of 
antibiotic resistance in urinary pathogens [8]. 
Urinary tract infection (UTI) is a frequent serious bacterial infection among population [9]. UTI is often 
associated with vesicoureteral reflux or urinary tract obstruction [10], conditions associated with a higher risk of 
recurrent UTI [11].  
Moreover, UTI is believed to be the leading cause of renal scarring [12, 13], one of the most common causes of 
end-stage renal disease in patients, the presumptive diagnosis of UTI in men is often based on the results of 
microscopic urinalysis (UA), and most infections remain undiagnosed if tests are not performed routinely to 
detect them [14, 15]. 
The sensitivity, specificity, and positive predictive value of the standard UA are so low that only a third to half of 
patients with positive urine culture results can be identified correctly. Dukes [16. 17] described a more accurate 
microscopic analysis of centrifuged urine performed with a hemocytometer and reporting cells per cubic 
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millimeter, herein referred to as hemocytometer white blood cell (WBC) counts.  
Stamm [18] defined pyuria as the presence of ≥10 WBCs/µL in centrifuged urine and found it to be very 
sensitive, identifying 96% of symptomatic adult patients with bacteriuria of ≥1000 colony-forming unit 
(CFU)/ml.  
The present study was undertaken to evaluate a group of febrile infants younger than 2 years of age to assess the 
usefulness of the WBC count, C-reactive protein (CRP) concentration, erythrocyte sedimentation rate (ESR), and 
UA for identifying infants at risk for UTI; and antibiotics sensitivity of each pathogen, in addition to compare 
standard WBC counts and hemocytometer WBC counts in identifying very young infants with positive urine 
culture results.  
 
Materials and methods 
Prospectively studied 200 patients (100 male and 100 female) who presented to the Pediatric Clinic or 
Emergency Department of Babylon Maternity and Children Hospital and Al-Hillah educational hospital from 
October\2012 to February\2013. All patients were being hospitalized and outpatients.  
Every patients underwent a history and physical examination, and a full evaluation for sepsis was performed, 
including peripheral WBC count and differential; ESR; CRP; blood culture (Blood samples were collected in 
screw capped tubes containing 20 ml Brain Heart Infusion broth without anticoagulant), Gram stain, and a UA 
and urine culture. Blood and urine specimens were cultured using standard media (Nutrient agar, MacConkey 
agar, Blood agar, Kleglar agar, Urea base agar, Peptone media, MR-VP broth and EMB agar) and using Vitic 
techniques to identification. Blood samples were cultured on aerobic and anaerobic media, also using Elisa 
technique from DRG (Germany) to determine the other non-cultivable bacteria like Ureaplasma urealyticum, 
Ureaplasma parvum, Mycoplasma hominis, Mycoplasma genetalium, and Chlamydia trachomatis. 
All urine specimens were obtained by clean containers with parent's assistance. Eligibility was limited to urine 
specimens of 3 mL obtained. All urinalyses were performed in a certified clinical laboratory. Specimens were 
analyzed with both standard UA and hemocytometer WBC counts simultaneously [18].  
For the standard UA, specimens were centrifuged at 2000 rpm for 10 minutes and were examined 
microscopically for pyuria reported as the number of leukocytes per high-power field. For hemocytometer WBC 
counts, the uncentrifuged urine specimens were examined microscopically on a Neubauer chamber (Neubauer 
hemocytometer) by the same technician. C-reactive protein test done using latex kit from HUMATEX CRP 
(Germany) for qualitative and semi-quantitative determination [19]. In this study used 34 different antibiotics to 
detect the sensitivity of UTI causative agents, using disk diffusion agar using Muller Hinton agar. 
Quantitative urine cultures were performed in the Microbiology Laboratory. A loop calibrated to deliver 0.01 mg 
was used to inoculate plates containing blood agar, nutrient agar, and MacConkey agar. All plates were incubated 
at 37°C and examined at 24 to 48 hours for colony count and bacterial identification. For standard UA, pyuria 
was defined as at least 5 WBCs/hfp. For hemocytometer WBC counts, pyuria was defined as at least 10 
WBCs/mL, cultures with growth of mixed organisms or nonpathogenic Gram-positive cocci were considered 
contaminated [20]. 
The antibacterial susceptibility testing of the isolates was done using the Kirby-Bauer disk diffusion method 
following the definition of the Clinical and Laboratory Standards Institute (CLSI, 2006) using antibiotics 
containing discs from Oxoid. Briefly, 20 ml of Mueller- Hinton agar (Himedia medium, India) was prepared and 
poured into sterile plates. The agar medium was allowed to solidify at room temperature on a flat bench.  
Then some few colonies of an 18 h culture of the isolates were streaked on the surfaces of the well-dried agar 
plates. Then some antibiotic discs were gently and firmly placed on the agar plates, which were then left at room 
temperature for 1 h to allow diffusion of the antibiotics into the agar medium. The plates were then incubated at 
35 - 37°C for 24 h. Zones of growth inhibition were then measured to the nearest millimetre and recorded. The 
mean of triplicate results was taken as the zone diameter.  
Results and Discussion 
This study investigated the percentage and antibiotic susceptibility patterns of bacterial pathogens isolated from 
patients with uncomplicated community-acquired UTI. The results showed that most cases of UTIs were caused 
by bacterial and viral pathogen. 
In this study, Escherichia coli formed the major causative agent (49%) followed by Pseudomonas aeruginosa 
(25%), Klebsiella pneumonia (18%) and Proteus species (8%) (Table 1).  
This is consistent with the findings of previous studies in which E. coli, Pseudomonas aeruginosa Klebsiella 
pneumonia and others were the predominant pathogen isolated from patients with UTIs [21]. Uropathogenic E. 
coli is the most common pathogen in cute UTI in previous studies [22]. 
This study shows the distribution and antibiotic susceptibility pattern of microbial species isolated from patients 
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with UTIs (Tables 3a, b). These organisms cause a variety of infections including UTIs [23]. Antibiotic 
resistance is a major clinical problem in treating infections caused by these microorganisms. The resistance to 
the antimicrobials has increased over the years. Resistance rates vary from country to country [24].  
Overall, isolates from Latin American countries show the lowest susceptibility rates to all antimicrobial agents 
followed by Asian-Pacific isolates and European strains. Strains from Canada exhibit the best global 
susceptibility testing results. In our study, it accounted for approximately all causative agents were belong to 
Enterobacteriaceae.   
This is consistent with the findings of previous studies in which E. coli was the predominant pathogen isolated 
from patients with community acquired UTIs [25]. However, Klebsiella pneumoniae are rarely encountered in 
cases of UTI [26]. In the present study 18% of Klebsiella isolates were found to be present among all 
uropathogens studied.  
These isolates shows sensitivity with Amikacin, Norfloxacin, Piperacillin, and Tobramycin which is consistent 
with the previous data of other community- based studies [27].  
Table 1: distribution of bacterial infections related to gender 
Type of Bacterial infection 
Male Female 
no. % no. % 
Ureaplasma urealyticum 16 2.4 22 3.3 
Ureaplasma parvum 7 1.0 3 0.4 
Mycoplasma hominis 8 1.2 19 2.8 
Mycoplasma genetalium 19 2.8 4 0.6 
Chlamydia trachomatis 17 2.5 17 2.5 
Streptococcus pyogenes 28 4.2 16 2.4 
Staphylococcus aureus 36 5.4 27 4.0 
Staphylococcus epidermidis 24 3.6 40 6.0 
Staphylococcus saprophyticus 3 0.4 49 7.3 
Escherichia coli 72 10.8 88 13.2 
Klebsiella pneumoniae 19 2.8 29 4.3 
Pseudomonas aeruginosa 27 4.0 31 4.6 
Provideneciae 14 2.1 11 1.6 
Serratiae marsescens 15 2.2 8 1.2 
Total 305 45.6 364 54.4 
 
E. coli isolates showed sensitivity with Amikacin, Chloromphenicol, Nitrofurantoin, Ofloxacin, Norfloxacin and 
Pseudomonas aeruginosa shows sensitivity with Norfloxacin, Ofloxacin, Piperacillin, Tobramycin, while Proteus 
species shows sensitivity with Amikacin, Amoxicillin , Cefodizime, Cefoxitin, Cephalexin, Gentamycin, , 
Norfloxacin, Piperacillin, Tobramycin,  it is nearly compatable with Indian, Taiwan, Spain, and Senegal isolates 
[28, 29].  
In this study E. coli, Pseudomonas aeruginosa, Proteus species and Klebsiella isolates are resistant against many 
antibiotics. Whereas, this drug exhibited low resistance rate in the major part of the world, despite of it's being 
used for many years [30]. This is probably due to the fact that this antibiotic has been widely used in treating 
community- acquired UTIs over the past decade in this region [31]. 
Other study revealed that 92 (65.7%) yielded bacterial growth with Staphylococcus aureus, S. saprophyticus and 
Escherichia coli having the highest incidence rate of 28.3%, 19.6% and 13.0%, respectively and that partially 
agreed with our results which was consist 25.69%. it revealed that E. coli (20.3%), Streptococcus agalactiae 
(13.4%), U. urealyiticum (11.8%), Staphylococcus epidermidis (9.7%) [32]. 
Leila, et al. 2007, publicized the frequency of Ureaplasma urealyticum (15%) was higher than that of 
Mycoplasma hominis (10.8%), Ureaplasma parvum (4.2%) and Mycoplasma genitalium (5%). Other study 
showed that infection was detected in (44.1%) of oligospermic subject and (74.7%) in azoospermic patients and 
that agreed with our results (40.3% and 53.3%) respectively. Staphylococcus aureus was indicates detected in 
one hundred and eighteen (68.2%) infected seminal fluids, Escherichia coli were detected in thirty one (17.9%) 
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[33]. 
 
Table 2: distribution of viral infections related to gender 
Type of Viral infection 
Male Female Male Female 
% no. % no. 
No. % No. % 
Rubella 5 3.3 11 7.3 
Herpes simplex I 11 7.3 18 12.0 
Herpes simplex II 22 14.7 39 26.0 
Cytomegalovirus 6 4.0 1 0.7 
Human papilloma virus 14 9.3 2 1.3 
Adeno-associated virus 1 0.7 0 0.0 
Epstein-Barr virus 5 3.3 15 10.0 
Total 64 42.7 86 57.3 
 
Table 2 revealed the percentage of viral infection among male and female suffering from urinary tract infection. 
It is showing that Herpes simplex II was the most common cause (22 male and 39 female) followed by Herpes 
simplex I as shown in table 2 above. 
In Greece Viral infection was detected in 143/172 (83.1%) of the total samples for at least one herpes virus: 
HSV-1, 2.5%; VZV, 1.2%; EBV, 45%; CMV, 62.5%; HHV-6, 70%; HHV-7, 0% in the normal semen samples 
and HSV-1, 2.1%; VZV, 3.2%; EBV, 39.1%; CMV, 56.5%; HHV-6, 66.3%; HHV-7, 0% in the abnormal semen 
samples [34]. 
The frequency of HSV, which was observed only in the 2.3% of the normozoospermic males, is at variance with 
the findings of Kapranos et al. but close to those demonstrated by Bezold, with the difference that they were 
detected in infertile males [35]. 
The detection rate of HSV-1/2 DNA in ejaculates from infertile patients in the current study was relatively high 
(3.7%). However, HSV was associated with the strongest effect of any of the pathogens on semen parameters. 
HSV infections had significantly reduced sperm concentration, sperm motility, motile sperm concentration, total 
motile sperm count, neutral α-glucosidase and citrate concentrations. Thus, HSV-infection of the male genital 
tract could explain some cases of male infertility, due to its association with decreased semen quality and that 
agreed with our results [36]. 
CMV is a member of the herpesvirus family and can cause a variety of teratogenic effects in newborns as well as 
a clinical illness in adults resembling infectious mononucleosis (Drew, et.al 1999). Its presence and persistence 
in semen has been reported previously. In the current study, CMV was detected in semen of infertility patients 
(20.42%). Detection of a low level of CMV in semen could reflect a recent infection in this individual. We did 
not observe a significant association of CMV DNA with semen parameters in this study, although other study 
revealed that there was a trend for lower motile sperm and α-glucosidase concentrations in the CMV-infected 
group, indicating that CMV infection could have a modest effect on semen quality, perhaps by affecting 
epididymal function. Previous studies have not shown an association of CMV infection with a reduction in 
semen parameters and that can explain the low ratio of CMV infection [37]. 
Human papillomaviruses represent a group of small DNA viruses that induce epithelial cell proliferation. More 
than 35 types of HPV infect the genital tract. DNA from HPV has been associated with invasive squamous cell 
cancers of the genital tract and anus [38]. HPV is primarily transmitted through direct epithelial contact, but high 
risk HPV types have been detected in both semen and spermatozoa, as well as in the vas deferens [39]. HPV was 
associated with a significant decrease in total sperm count, and a statistically non-significant trend for lower total 
motile sperm count and neutral α-glucosidase concentrations. A previous study reported an association between 
HPV and reduced sperm, EBV, a member of the herpesvirus family, causes infectious mononucleosis and has 
been associated with Burkitt's lymphoma. EBV is found in semen and is thought to be sexually transmitted [40]. 
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Table 3a: Antimicrobial potency and spectrum of 13 selected antimicrobial agents tested against most frequently 
occurring UTI pathogens. 
Microorganism 
Antimicrobial agent / % sensitive strains 
AK AX AMC AZM B PY CDZ FOX ZOX CL C CLR DA 
Escherichia  coli 80 33 25 26 - - - - 10 20 90 - - 
Pseudomonas 
aeruginosa 
65 17 36 - 19 - 10 15 15 55 15 10 - 
Klebsiella pneumoniae 87 8 14 34 - 10 - - 10 5 - 10 - 
Proteus species 93 71 98 16 20 55 80 95 35 75 25 55 25 
Streptococcus pyogenes 80 80 - 5 - 10 95 - 10 15 80 75 5 
Staphylococcus aureus 90 - 10 1 5 10 50 - - - - 10 - 
Staphylococcus 
epidermidis 
- 10 45 30 - - 50 25 80 50 45 70 - 
Staphylococcus 
saprophyticus 
70 64 18 - 34 28 64 18 15 29 67 90 - 
Providencia stuartii 76 67 76 48 15 - 19 - 42 19 65 10 38 
Serratia marcescens 80 80 84 27 15 45 62 86 20 76 20 46 16 
 
 
AK \Amikacin, AX \Amoxicillin, AMC \Amoxicillin + Clavulanic acid, AZM \Azithromycin, , B \Bacitracin, PY 
\Carbenicillin, CDZ \Cefodizime, FOX \Cefoxitin, ZOX \Ceftizoxime, CL \Cephalexin, C \Chloromphenicol, 
CLR \Clarithromycin, DA \Clindamycin 
 
Table 3b: Antimicrobial potency and spectrum of 13 selected antimicrobial agents tested against most frequently 
occurring UTI pathogens. 
Microorganism 
Antimicrobial agent / % sensitive strains 
E CN K L ME F NOR OFX OX T P PRL RA 
Escherichia  coli 88 20 20 - 5 - - - 10 20 90 - - 
Pseudomonas aeruginosa 55 10 20 10 10 - 10 15 15 55 15 10 - 
Klebsiella pneumoniae 80 - - 25 - 10 - - 10 5 - 10 - 
Proteus species 100 60 90 10 20 55 80 95 35 75 25 55 25 
Streptococcus pyogenes 30 80 80 95 20 90 90 95 85 95 25 5 75 
Staphylococcus aureus 20 5 10 10 - 70 95 - 15 50 5 - - 
Staphylococcus 
epidermidis 
- 10 - 25 5 - - 70 - 10 - 5 45 
Staphylococcus 
saprophyticus 
65 88 - 5 15 10 95 - 16 15 80 81 12 
Providencia stuartii 75 14 18 10 16 35 19 10 5 - - 28 24 
Serratia marcescens 90 57 80 17 35 40 64 67 54 68 30 19 5 
E \Erythromycin, CN\Gentamycin, K\Kanamycin, L\Lincomycin, ME\Methicillin, F\Nitrofurantoin, 
NOR\Norfloxacin, OFX \Ofloxacin, OX\Oxacillin, T\Oxytetracyclin, P\Penicillin  G, PRL \Piperacillin, 
RA\Rifampim. 
 
These results were done according to performance standards for antimicrobial disk susceptibility tests, CLSI 
(formerly NCCLS). The antibiotic which not including in CLSI chart, FDA approved performance standards for 
antimicrobial discs obtained from drug manufactures [41]. 
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Table 4: The Results of Diagnostic Test in Presence of a Positive Urine Culture. 
Diagnostic Test 
Male Female 
No. % No. % 
Standard UA > 5 WBCs/hpf 62 62 84 84 
Hemocytometer WBC Counts >10 WBCs/mL 84 84 75 75 
CRP > 24 mg/L 86 86 64 64 
ESR > 35 mm/h 67 67 70 70 
Peripheral WBC > 15 000/mL 69 69 55 55 
 
CRP >20 mg/L, ESR >30 mm/hour, and WBC >15 000/mL are key findings in various studies on febrile infants 
[25]. The diagnostic value of these parameters for predicting serious bacterial infection in febrile infants, CRP is 
an acute phase reactant which opsonizes invading pathogens. Levels of CRP increase within 6 hours of an 
inflammatory stimulus, and may rise up to 1000-fold, measurement of CRP provide direct index of acute 
inflammation, in contrast to CRP, the ESR is an indirect measure of the acute phase response [42]. 
 
Our investigation showed that from the 200 patients with UTI, 62 male and 84 had pyuria > 5 WBCs/hpf, 84 
male and 75 female had pyuria >10 WBCs/mL, 86 male and 64 female had CRP >24 mg/L, 67 male and 70 
female had ESR >35 mm/hour, and 69 male and 55 female had WBC >15 000/ml. Our results corroborate the 
findings of Crain and Dar-Shong [43, 44] whose sample was similar to ours.  
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